Table 1: Clinical manifestations and route of exposure in some patients with metallic mercury poisoning reported from different countries.
Age (yrs)/sex	Route of exposure	Clinical manifestations	Elemental mercury concentration (μg/L)	Treatment	Country	Reference
67/Male	Ingestion, inhalation (suicidal attempt)	Severe pneumonitis, ARF*, anuria	Blood: 1577	Hemodialysis, No chelating therapy	Japan	12
46/Female	Manometer used in the arterial line	Severe pain, ischemia, erythematous lesions, cyanosis of the left hand	Blood: 192.9	Nitroglycerin patches, codeine, acetaminophen, and penicillamine	Brazil	13
40/Male	Self-injection of elemental mercury	Schizophrenia and inflammatory soft tissue lesions	24-h urine: 6	Broad-spectrum antibiotics, surgical debridement of necrotic tissue	USA	14
21/Male	Self-injection of elemental mercury by breaking thermometers	Granuloma in the antecubital fossa	Serum: 11	Surgical removal of mercury	Georgia	15
22/Male	Repeated self-administration of metallic mercury injection	Arthromyalgias, fever, weakness, chest pain (multiple punctuates metallic densities in radiographs)	Blood: 370	Mercury micro-emboli management	Spain	16
36/Male	Chronic mercury vapor exposure and possible iv injection	Rash, sore throat, fever, chills, cough and diarrhea	N/A	Chelating therapy with DMSA† and DMPS‡	USA	17
36/Female	Heating the liquid form of mercury	Abdominal pain, diarrhea and fever	Not tested on admission—blood: 300 at discharge	Symptomatic chelation treatment with N-acetyl cysteine (NAC)	Turkey	18
*ARF: Acute renal failure; †DMSA: Dimercaptosuccinic acid; ‡DMPS: Dimercapto-propane-sulfonic acid; N/A: Not available